Robert Steger
State University of New York System
3 Papers
24 Citations
Robert Steger is an academic researcher from State University of New York System. The author has contributed to research in topics: Kinin & Kininogen. The author has an hindex of 2, co-authored 3 publications.
Chat about Author
Papers
Effect of aprotinin, EACA and heparin on growth and vasopeptide system of Murphy-Sturm lymphosarcoma.
Nathan Back,Robert Steger +1 more
TL;DR: The tumor inhibition and biochemical data suggest the involvement of proteases in the neoplastic process and aprotinin and heparin significantly inhibited tumor growth by the 15th day, compared to control, saline-administered animals.
15
Kinin-Forming Activity of Cultured Mouse Fibroblasts L-929
Nathan Back,Robert Steger +1 more
TL;DR: None of the conventional plant, mammalian, or synthetic protease inhibitors had any significant effect on the kinin-forming activity of the fibroblasts, however, Phenylpyruvic acid did inhibit this activity.
7
Low molecular weight organic acids as inhibitors of kinin-forming activity of a rodent tumor acid protease and human plasma kallikrein.
TL;DR: Low molecular weight organic acids were studied in vitro against the kinin-forming activity of human plasma kallikrein and an acid protease isolated from the rodent Murphy Sturm lymphosarcoma to find phenyl lactic, phenyl pyruvic, p-hydroxy phenylpyruvic and α-keto isocaproic acids were most effective at concentrations 7.5×10 −3 M against the tumor acid prote enzyme.
2